Oncostellae

Development of new pharmaceutical compounds for the treatment of inflamed intestine, colon cancer and immune diseases

Total raised

€4.3M

€4,300,000

Funding rounds

Investors

distinct backers

Active since

2022-07

latest 2023-07

Funding by year

EUR raised per year

High confidence

Raise-next likelihood19

base rate 30% for Other

Exit likelihood16

base rate 12% (2+ rounds)

Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

4 rounds

Date	Stage	Amount	Investors
2023-07-05	Other	€500k	Bio & Tech Smart Capital FCRE,Noso Capital SGEIC,Santiago Domínguez	View deal →
2022-11-23	Crowdfunding	€2.0M	Capital Cell	View deal →
2022-11-23	Other	€1.3M	Fitalent,Inveready,Unirisco,XesGalicia	View deal →
2022-07-06	Debt	€500k	Fitalent,Inveready,Julio Castro,XesGalicia	View deal →

same sector or country